Robert D. McQuade, PhD

Letter to the Editor

Reply to Aripiprazole and Perphenazine: No Difference

November 15, 2007

Original Research

Aripiprazole Monotherapy for Maintenance Therapy in Bipolar I Disorder: A 100-Week, Double-Blind Study Versus Placebo

October 15, 2007

Original Research

Antimanic Response to Aripiprazole in Bipolar I Disorder Patients Is Independent of the Agitation Level at Baseline

September 17, 2007

Original Research

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

June 15, 2007

Original Research

Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine

February 15, 2007

Original Research

Efficacy and Safety of Intramuscular Aripiprazole in Patients With Acute Agitation: A Randomized, Double-Blind, Placebo-Controlled Trial

January 15, 2007

Original Research

A Randomized, Double-Blind, Placebo-Controlled 26-Week Trial of Aripiprazole in Recently Manic Patients With Bipolar I Disorder.

April 15, 2006

Original Research

Efficacy of Aripiprazole Against Hostility in Schizophrenia and Schizoaffective Disorder: Data From 5 Double-Blind Studies

November 15, 2005

Article

A Comparison of Weight Change During Treatment With Olanzapine or Aripiprazole: Results From a Randomized, Double-Blind Study

December 15, 2004

Original Research

Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder

September 23, 2002

Original Research

Reemergence of Sexual Dysfunction in Patients With Major Depressive Disorder: Double-Blind Comparison of Nefazodone and Sertraline

January 1, 2001